- The Supreme Court heard petitions on medicine, medical equipment and generic pharmaceutical pricing
- It expressed concern over the sharp disparity between the Price to Retailer (PTR) and consumer price, notably in the case of cancer drugs.
- It asked whether the 16% retailer margin under the DPCO, 2013 could not be extended to other essential medicines also. Read More
India’s mechanism for governing drug prices
In News
Observations of SC